Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-27

Clinical Trial Update: Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo [Phase 2]

View source ↗

Summary

Phase 2 trial comparing a new bifonazole spray with terbinafine topical solution and placebo for treating tinea pedis, with study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifonazole Spray (bifonazole)
  • Terbinafine Topical Solution (terbinafine)

Snippet

Sponsor: Bayer | Conditions: Tinea Pedis | Phase 2 | Status: COMPLETED